Charlotte Beau-Larvor

Absolute and multiplex quantification of antibodies in serum using PSAQ™ standards and LC-MS/MS.

M. Jaquinod, A. Beck, V. Brun, 2015, Bioanalysis.

A new anti-human Fc method to capture and analyze ADCs for characterization of drug distribution and the drug-to-antibody ratio in serum from pre-clinical species.

A. Beck, L. Troncy, Marie-Claire Janin-Bussat, 2016, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

A New Anti-CXCR4 Antibody That Blocks the CXCR4/SDF-1 Axis and Mobilizes Effector Cells

C. Bailly, C. Dumontet, A. Robert, 2016, Molecular Cancer Therapeutics.

Abstract #835: First bivalent fully antagonist anti-c-Met antibody targeting the c-Met receptor: I) in vitro mechanism of action

C. Bailly, T. Wurch, A. Robert, 2009 .

A novel antagonist anti‐cMet antibody with antitumor activities targeting both ligand‐dependent and ligand‐independent c‐Met receptors

C. Bailly, A. Robert, A. Beck, 2016, International journal of cancer.

Efficacy of the Antibody–Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors

C. Dreyfus, A. Robert, A. Beck, 2019, Molecular Cancer Therapeutics.

A novel role for junctional adhesion molecule‐A in tumor proliferation: Modulation by an anti‐JAM‐A monoclonal antibody

C. Bailly, A. Robert, L. Zanna, 2013, International journal of cancer.

A novel role for junctional adhesion molecule‐A in tumor proliferation: Modulation by an anti‐JAM‐A monoclonal antibody

C. Bailly, A. Robert, L. Zanna, 2013, International journal of cancer.

A New Anti-CXCR4 Antibody That Blocks the CXCR4/SDF-1 Axis and Mobilizes Effector Cells

C. Bailly, C. Dumontet, A. Robert, 2016, Molecular Cancer Therapeutics.